These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 20402317
1. Epidemiology of multiple sclerosis in western Herzegovina and Herzegovina--Neretva Canton, Bosnia and Herzegovina. Klupka-Sarić I, Galić M. Coll Antropol; 2010 Mar; 34 Suppl 1():189-93. PubMed ID: 20402317 [Abstract] [Full Text] [Related]
2. Epidemiology of multiple sclerosis in western Herzegovina. Klupka-Sarić I, Ristić S, Sepcić J, Kapović M, Peterlin B, Materljan E, Jurisić T, Mamić DM, Burina A, Sulentić V. Clin Neurol Neurosurg; 2007 Nov; 109(9):779-83. PubMed ID: 17766036 [Abstract] [Full Text] [Related]
3. Multiple sclerosis in Isfahan, Iran. Saadatnia M, Etemadifar M, Maghzi AH. Int Rev Neurobiol; 2007 Nov; 79():357-75. PubMed ID: 17531850 [Abstract] [Full Text] [Related]
4. Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey. Papathanasopoulos P, Gourzoulidou E, Messinis L, Georgiou V, Leotsinidis M. Neuroepidemiology; 2008 Nov; 30(3):167-73. PubMed ID: 18382116 [Abstract] [Full Text] [Related]
5. Ulcerative colitis in the Tuzla region of Bosnia and Herzegovina between 1995 and 2006: epidemiological and clinical characteristics. Salkic NN, Pavlovic-Calic N, Gegic A, Jovanovic P, Basic M. Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):346-53. PubMed ID: 19474740 [Abstract] [Full Text] [Related]
6. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries? Al-Araji A, Mohammed AI. J Neurol Sci; 2005 Jul 15; 234(1-2):67-71. PubMed ID: 15946690 [Abstract] [Full Text] [Related]
7. Prevalence and incidence of multiple sclerosis in Panama (2000-2005). Gracia F, Castillo LC, Benzadón A, Larreategui M, Villareal F, Triana E, Arango AC, Lee D, Pascale JM, Gomez E, Armien B. Neuroepidemiology; 2009 Jul 15; 32(4):287-93. PubMed ID: 19246933 [Abstract] [Full Text] [Related]
8. [Iodine deficiency in the Federation of Bosnia and Herzegovina]. Tahirović H, Toromanović A, Hadzibegić N, Stimljanin D, Budimić Z, Cengić H, Roncević Z, Denjo E, Huskić J, Hadzimujić I, Moro D, Ivanković A, Dodig N, Hasanbegović S. Med Arh; 2000 Jul 15; 54(3):153-8. PubMed ID: 11117011 [Abstract] [Full Text] [Related]
9. Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia. Peterlin B, Ristić S, Sepcić J, Vracko BK, Rako A, Lovrecić L, Brajenović-Milić B, Rudez J, Materljan E, Kapović M. J Neurol Sci; 2006 Sep 25; 247(2):169-72. PubMed ID: 16806273 [Abstract] [Full Text] [Related]
10. Natural history of multiple sclerosis: a unifying concept. Confavreux C, Vukusic S. Brain; 2006 Mar 25; 129(Pt 3):606-16. PubMed ID: 16415308 [Abstract] [Full Text] [Related]
11. [Multiple sclerosis in the Bern canton (Switzerland). An epidemiologic study]. Beer S, Kesselring J. Fortschr Neurol Psychiatr; 1988 Dec 25; 56(12):394-401. PubMed ID: 3266180 [Abstract] [Full Text] [Related]
12. High prevalence of multiple sclerosis in the Swedish county of Värmland. Boström I, Callander M, Kurtzke JF, Landtblom AM. Mult Scler; 2009 Nov 25; 15(11):1253-62. PubMed ID: 19805442 [Abstract] [Full Text] [Related]
13. Prevalence of multiple sclerosis in the Serbian district Sumadija. Toncev G, Miletic Drakulic S, Knezevic Z, Boskovic Matic T, Gavrilovic A, Toncev S, Drulovic J, Pekmezovic T. Neuroepidemiology; 2011 Nov 25; 37(2):102-6. PubMed ID: 21921643 [Abstract] [Full Text] [Related]
14. [Topographic distribution of multiple sclerosis in the Belgrade municipalities]. Pekmezović T, Jarebinski M, Drulović J, Stojsavljević N, Peković N, Lević Z. Srp Arh Celok Lek; 2001 Nov 25; 129(1-2):5-8. PubMed ID: 11534282 [Abstract] [Full Text] [Related]
15. Possible increasing risk of multiple sclerosis in Catania, Sicily. Nicoletti A, Patti F, Lo Fermo S, Sorbello V, Reggio E, Maimone D, Zappia M, Reggio A. Neurology; 2005 Oct 25; 65(8):1259-63. PubMed ID: 16247054 [Abstract] [Full Text] [Related]
16. Is late-onset multiple sclerosis associated with a worse outcome? Tremlett H, Devonshire V. Neurology; 2006 Sep 26; 67(6):954-9. PubMed ID: 17000960 [Abstract] [Full Text] [Related]
17. Clinical characteristics of multiple sclerosis in Lebanon. Yamout B, Barada W, Tohme RA, Mehio-Sibai A, Khalifeh R, El-Hajj T. J Neurol Sci; 2008 Jul 15; 270(1-2):88-93. PubMed ID: 18367208 [Abstract] [Full Text] [Related]
18. [Prevalence and characteristics of multiple sclerosis in the health district of the Marina Alta]. García-Gallego A, Morera-Guitart J. Rev Neurol; 2008 Jul 15; 34(8):732-7. PubMed ID: 12080492 [Abstract] [Full Text] [Related]
19. [Epidemiology and clinical evolutionary aspects of multiple sclerosis in Navarra]. Antón Aranda E, Martínez-Lage JM, Maraví Petri E, Gállego Culleré J, de Castro P, Villanueva Eusa JA. Neurologia; 1991 May 15; 6(5):160-9. PubMed ID: 1873044 [Abstract] [Full Text] [Related]
20. The occurrence of autoimmune diseases in patients with multiple sclerosis and their families. Henderson RD, Bain CJ, Pender MP. J Clin Neurosci; 2000 Sep 15; 7(5):434-7. PubMed ID: 10942666 [Abstract] [Full Text] [Related] Page: [Next] [New Search]